Abstract: A 3D display panel includes a plurality of first and second viewing angle pixels arranged along a first direction for displaying first and second viewing angle images respectively. The first viewing angle pixels and the second viewing angle pixels are interlacedly arranged along a second direction. A method for controlling pixel brightness of the 3D display panel includes determining a brightness value of a first block of a first viewing angle pixel according to a brightness value of the first viewing angle pixel and a brightness value of a second viewing angle pixel next to the first viewing angle pixel along the second direction, and determining a brightness value of a second block of the first viewing angle pixel according to the brightness value of the first block of the first viewing angle pixel and the brightness value of the first viewing angle pixel.

Abstract: The present invention provides a compound of Formula (1): as described herein or a pharmaceutically acceptable salt or solvate thereof. The compounds are useful as inhibitors of the HDM2 protein. Also disclosed are pharmaceutical compositions comprising the above compounds and potential methods of treating cancer using the same.

Abstract: The present invention provides a compound of Formula 1 as described herein or a pharmaceutically acceptable salt, solvate or ester thereof. The compounds are useful as inhibitors of the HDM2 protein. Also disclosed are pharmaceutical compositions comprising the above compounds and methods of treating cancer using the same.

Abstract: Disclosed is a micro-blog sorting method, in which micro-blog information requested by a micro-blog requesting user is acquired, micro-blog posting user information and content information are extracted from the micro-blog information to score the micro-blog information, the micro-blog information is sorted according to the score and the micro-blog information is presented according to a sorted result. With the above micro-blog sorting method, the micro-blog posting user information as well as the content information in the micro-blog information are extracted to score the micro-blog information, the micro-blog information is sorted according to the score, and the micro-blog information related to the user is sorted close to the top, and thus it is convenient for the user to view the micro-blog information. In addition, a micro-blog sorting system and a micro-blog searching and presenting method and system are also provided.

Abstract: A mechanism is provided for thin provisioning. An original time-domain sequence of a load parameter of storage resources already allocated to an application program is collected. A future load peak time period of the storage resources already allocated to the application program is determined based on the collected original time-domain sequence of the load parameter. A new storage resource unit from a high-speed storage is allocated in response to receipt of a request to allocate the new storage resource unit to the application program in the future load peak time period. On an occasion of thin provisioning, whether the physical storage resources newly allocated to the application program are located in a low-speed storage or a high-speed storage is determined according to the accesses of the application program to the already-allocated physical storage resources.

Abstract: A storage system is dynamically reconfigured. The storage system includes storage pools that each include one or more storage disks. Storage pools to be expanded are determined as target storage pools. For the target storage pools, source storage disks to be moved into the target storage pools are determined from other storage pools than the target storage pools in the storage system. The source storage disks are migrated to the respective target storage pools.

Abstract: The present invention discloses chemical synthesis, anti-tumor and anti-metastatic effects of a dual functional conjugate as shown by formula I. Specifically, paclitaxel or docetaxol is linked with muramyl dipeptide derivative to form a conjugate, thus dual anti-tumor and anti-metastatic effects are achieved by combination of chemotherapy and immunotherapy. The present invention also discloses that paclitaxel or docetaxol and muramyl dipeptide derivative conjugate is synthesized by combination of solid-phase and solution-phase synthesis, and said conjugate can be used in manufacture of anti-tumor medicaments as proved by reliable bioassays.

Abstract: A 3D display panel includes a plurality of first and second viewing angle pixels arranged along a first direction for displaying first and second viewing angle images respectively. The first viewing angle pixels and the second viewing angle pixels are interlacedly arranged along a second direction. A method for controlling pixel brightness of the 3D display panel includes determining a brightness value of a first block of a first viewing angle pixel according to a brightness value of the first viewing angle pixel and a brightness value of a second viewing angle pixel next to the first viewing angle pixel along the second direction, and determining a brightness value of a second block of the first viewing angle pixel according to the brightness value of the first block of the first viewing angle pixel and the brightness value of the first viewing angle pixel.

Abstract: The present invention provides a compound of Formula (1) as described herein or a pharmaceutically acceptable salt, solvate or ester thereof. The compounds are useful as inhibitors of the HDM2 protein. Also disclosed are pharmaceutical compositions comprising the above compounds and methods of treating cancer using the same.

Abstract: The present invention relates to HDM2 polypeptides and mutants thereof which are complexed with various compounds, e.g., HDM2 inhibitors.

Abstract: In its many embodiments, the present invention discloses novel compounds, as inhibitors of HDM2 protein methods for preparing such compounds, pharmaceutical compositions including one or more such compounds, methods of treatment, prevention, inhibition, of one or more diseases associated with the HDM2 protein or P53 using such compounds or pharmaceutical compositions.

Abstract: The present invention relates to HDM2 polypeptides and mutants thereof which are complexed with various compounds, e.g., HDM2 inhibitors.

Abstract: The present invention relates to HDM2 polypeptides and mutants thereof which are complexed with various compounds, e.g., HDM2 inhibitors.

Abstract: The present invention discloses a method of using compounds, which have HDM2 protein antagonist activity, to treat or prevent cancer, other diseases caused by abnormal cell proliferation, diseases associated with HDM2, or diseases caused by inadequate P53 activity.

Abstract: In its many embodiments, the present invention discloses novel compounds, as inhibitors of HDM2 protein, methods for preparing such compounds, pharmaceutical compositions including one or more such compounds, methods of treatment, prevention, inhibition, of one or more diseases associated with the HDM2 protein or P53 using such compounds or pharmaceutical compositions.